**1. Introduction**

74 Liver Tumors

Thelen, A., A. Scholz, et al. (2008). Tumor-associated lymphangiogenesis correlates with

Thelen, A., Scholz A., Benckert, C., Weichert, W., Dietz, E., Wiedenmann, B., Neuhaus, P., &

Tlsty, T. D. (2001). Stromal cells can contribute oncogenic signals. *Semin Cancer Biol* Vol 11

Tominaga, S. and Kuroishi T. (1994). Biliary tract cancer. *Cancer Surv* Vol 19-20, pp 125-37.

Tuxhorn, J. A., Ayala G. E., & Rowley, D.R. (2001). Reactive stroma in prostate cancer progression. *J Urol* Vol 166, Issue 6 (Dec 2001), pp 2472-83. ISSN 0022-5347. Utispan, K., Thuwajit P., Abiko, Y., Charngkaew, K., Paupairoj, A., Chau-in, S., & Thuwajit,

Veikkola, T., Jussila L., Makinen, T., Karpanen, T., Jeltsch, M., Petrova, T.V., Kubo, H.,

Xu, L. B., Liu C., Gao, G.Q., Yu, X.H., Zhang, R., & Wang, J. (2010). Nerve growth factor-beta

Yabuuchi, S., Katayose Y., Oda, A., Mizuma, M., Shirasou, S., Sasaki, T., Yamamoto, K.,

Yoshikawa, D., Ojima H., Iwasaki, M., Hiraoka, N., Kosuge, T., Kasai, S., Hirohashi, S., &

Yoshikawa, D., Ojima H., Kokubu, A., Ochiya, T., Kasai, S., Hirohashi, S., & Shibata, T.

*Rep* Vol 15 Issue 3 (Mar 2006), pp 525-32. ISSN 1021-335X.

Vol 105, Issue 5 (Mar 2010) pp 1123-32. ISSN 1534-4681.

prognostic marker. *Mol Cancer* Vol 9, pp 13. ISSN 1476-4598.

Issue 2 (Apr 2001) pp 97-104. ISSN 1044-579X.

Vol 15 Issue 3 (Mar 2008), pp 791-9.

ISSN 0261-2429.

31. ISSN 0261-4189.

45. ISSN 1432-2323.

2009) pp 1169-80. ISSN 0250-7005.

Issue 8 (Apr 2009), pp 1257-66. ISSN 1532-1827.

pp 418-25. ISSN 0007-0920.

Umeshita, K., Dono, K., Wakasa, K., & Monden, M. (2006). Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance. *Oncol* 

lymph node metastases and prognosis in hilar cholangiocarcinoma. *Ann Surg Oncol*

Jonas, S. (2010). Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic Cholangiocarcinoma. *Am J Gastroenterol.* 

C. (2010). Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor

Thurston, G., McDonald, D.M., Achen, M.G., Stacker, S.A., & Alitalo, K. (2001). Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. *EMBO J* Vol 20 Issue 6 (Mar 2001), pp 1223-

expression is associated with lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma. *World J Surg* Vol 34, Issue 5 (May 2010), pp 1039-

Oikawa, M., Rikiyama, T., Onogawa, T., Yoshia, H., Ohtuska, H., Motoi, F., Egawa, S., & Unno, M. (2009). ZD1839 (IRESSA) stabilizes p27Kip1 and enhances radiosensitivity in cholangiocarcinoma cell lines. *Anticancer Res* Vol 29 Issue 4 (Apr

Shibata, T. (2008). Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. *Br J Cancer* Vol 98, Issue 2 (Jan 2008),

(2009). Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma. *Br J Cancer* Vol 100,
